Intelligent Bio Solutions (INBS) Change in Accured Expenses (2022 - 2025)

Intelligent Bio Solutions' Change in Accured Expenses history runs 4 years deep, the most recent figure standing at $237202.0 for Q1 2025.

• In Q1 2025, Change in Accured Expenses rose 208.11% year-over-year to $237202.0; the TTM figure through Mar 2025 stood at -$774248.0 (down 261.22% YoY), while the FY2023 annual figure was -$25724.0, down 189.15% from the prior year.
• Change in Accured Expenses was $237202.0 for Q1 2025 at Intelligent Bio Solutions, up from -$1.0 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $237202.0 in Q1 2025 to a low of -$1.0 million in Q4 2024.
• Historically, Change in Accured Expenses has averaged -$70982.2 across 4 years, with a median of $2261.0 in 2023.
• Biggest YoY gain for Change in Accured Expenses was 7721.02% in 2024; the steepest drop was 44920.26% in 2024.
• A 4-year view of Change in Accured Expenses shows it stood at $2905.0 in 2022, then retreated by 22.17% to $2261.0 in 2023, then plunged by 44920.26% to -$1.0 million in 2024, then jumped by 123.41% to $237202.0 in 2025.
• The last three Change in Accured Expenses figures came in at $237202.0 (Q1 2025), -$1.0 million (Q4 2024), and $221335.0 (Q3 2024), per Business Quant data.